ArticleJournal of the National Cancer Institute2021

Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients.

Gwen M H E Dackus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.